Progentec Gains Additional Funding for Lupus Detection and Management Platforms

By sarah | News | 0 comment | 8 December, 2018 | 0

By Mary Chapman
Lupus News Today
Copyright © 2013-2018 All rights reserved.

Completion of a second round of funding could help bring closer to market Progentec Diagnostics‘ new tool for predicting lupus flares and a biomarker-based index that monitors underlying disease activity.

Funding for Progentec’s biomarker-based diagnostic testing was led by venture capital outfits i2E and OCA Ventures, with participation by global healthcare provider NMC Lifesciences. Using technology created by the Oklahoma Medical Research Foundation, the platform is touted as being able to detect impending flares and track underlying disease movement.

“Today’s funding round is the next step on our journey to making this and other advanced tools commercially available to patients with lupus, a disease that afflicts more than one million Americans, many of whom are women,” Mohan Purushothaman, PhD, Progentec’s CEO, said in a press release. “The Progentec tests will become powerful tools to help patients and healthcare providers stay ahead of lupus.”

Read the entire story at Lupus News Today

Lupus News Today, Mohan Purushothaman, Progentec Diagnostics

OKC-based Progentec Diagnostics refines test to predict future lupus flares

By sarah | 0 comment

By Jim Stafford Copyright © 2019, The Oklahoman Five patients are waiting to see their doctor, each displaying different symptoms. One has a bright rash on her face. Another is suffering from arthritis. Still anotherRead more
Progentec Diagnostics Raises Funds to Support Advances in Lupus Detection and Management

By sarah | 0 comment

– New funding brings lupus-detection tools closer to commercialization – Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Nov. 1, 2018 /PRNewswire/ — Progentec Diagnostics, Inc. (“Progentec”), aRead more
Predicting the lupus flare

By sarah | 0 comment

Oklahoma-based Progentec Diagnostics develops suite of tools to diagnose and manage painful autoimmune disease The Lupus Foundation of America estimates there are 1.5 million Americans who are afflicted with lupus, a chronic autoimmune disease inRead more
Oklahoma’s bioscience prowess busy making a difference worldwide

By sarah | 0 comment

By Kevan Goff-ParkerCopyright © 2019 The Oklahoman Greater Oklahoma City Chamber Manager of Innovation and Entrepreneurship Evan Fay said he believes some people may be caught off-guard by Oklahoma’s growing bioscience prowess. He made hisRead more
Progentec gets i2E funding

By sarah | 0 comment

By Journal Record Staff Courtesy of the Journal Record OKLAHOMA CITY – Progentec Diagnostics Inc. has completion a second round of funding led by i2E, along with Chicago-based OCA Ventures and NMC Lifesciences, aRead more